Leàn Rolfes
Impact in
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions
-
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 22
- Pharmacovigilance and Adverse Drug Reactions 22
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Florence P. A. M. van Hunsel (15 shared papers)Eugène van Puijenbroek (18 shared papers)Katja Taxis (3 shared papers)Linda Härmark (6 shared papers)Kees van Grootheest (3 shared papers)Tim Schutte (3 shared papers)Lara Magro (1 shared paper)Andries S. Koster (1 shared paper)
- Journals
- Drug Safety (6 papers)Expert Opinion on Drug Safety (4 papers)Pharmacoepidemiology and Drug Safety (4 papers)Clinical Therapeutics (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- NetherlandsIndiaSweden
In The Last Decade
Leàn Rolfes
26 papers receiving 449 citations
Peers
Comparison fields: 5 of 51
- Toxicology 362
- Geriatrics and Gerontology 11
- Pharmacology 20
- Infectious Diseases 35
- Family Practice 3
Countries citing papers authored by Leàn Rolfes
This map shows the geographic impact of Leàn Rolfes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leàn Rolfes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leàn Rolfes more than expected).
Fields of papers citing papers by Leàn Rolfes
This network shows the impact of papers produced by Leàn Rolfes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leàn Rolfes. The network helps show where Leàn Rolfes may publish in the future.
Co-authors
The 22 scholars most cited alongside Leàn Rolfes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 75 | |
| 2 | 2014 | 67 | |
| 3 | 2018 | 57 | |
| 4 | 2016 | 52 | |
| 5 | 2017 | 29 | |
| 6 | 2022 | 29 | |
| 7 | 2013 | 24 | |
| 8 | 2019 | 20 | |
| 9 | 2017 | 17 | |
| 10 | 2018 | 14 | |
| 11 | 2016 | 12 | |
| 12 | Cervical dysplasia associated with the use of natalizumab. | 2013 | 11 |
| 13 | 2015 | 10 | |
| 14 | 2022 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2018 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2019 | 5 | |
| 19 | 2019 | 4 | |
| 20 | 2016 | 3 |
About Leàn Rolfes
Leàn Rolfes is a scholar working on Toxicology, Infectious Diseases, Cardiology and Cardiovascular Medicine, Health Information Management and Obstetrics and Gynecology, having authored 28 papers that have together received 465 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (22 papers), Atrial Fibrillation Management and Outcomes (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cervical Cancer and HPV Research (1 paper), Pregnancy and preeclampsia studies (1 paper), Health Education and Validation (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Statistical Methods in Epidemiology (1 paper). The work is most often cited by research in Toxicology (362 citations), Geriatrics and Gerontology (11 citations), Pharmacology (20 citations), Infectious Diseases (35 citations) and Family Practice (3 citations). Leàn Rolfes has collaborated with scholars based in Netherlands, India and Sweden. Frequent co-authors include Florence P. A. M. van Hunsel, Eugène van Puijenbroek, Katja Taxis, Linda Härmark, Kees van Grootheest, Tim Schutte, Lara Magro, Andries S. Koster, Daisuke Tanaka and Gurumurthy Parthasarathi. Their work appears in journals such as Drug Safety, Expert Opinion on Drug Safety, Pharmacoepidemiology and Drug Safety, Clinical Therapeutics and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.